These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39069851)

  • 1. [Clinical features of pulmonary hypertension in lymphangioleiomyomatosis].
    Liang PQ; Xu BN; Pan YX; Huang HY; Zhao Z; Hong C; Wu XF; Liu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Aug; 47(8):746-753. PubMed ID: 39069851
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
    Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
    Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
    Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
    Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis.
    Yoon HY; Moon SJ; Kim SY; Park JS; Choi SM; Kang HK; Song JW
    Ther Adv Respir Dis; 2024; 18():17534666241272928. PubMed ID: 39148439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
    Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
    Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
    Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
    Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.
    Radzikowska E; Jaguś P; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
    Respir Med; 2015 Nov; 109(11):1469-75. PubMed ID: 26386638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.
    Taveira-DaSilva AM; Hathaway OM; Sachdev V; Shizukuda Y; Birdsall CW; Moss J
    Chest; 2007 Nov; 132(5):1573-8. PubMed ID: 17890459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
    Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
    PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
    Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
    Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.
    Hua W; Yang W; Gu J; Wu J; Wang W; Liu Y; Zhu H; Zhou M; Qu J; Fang Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):439-448. PubMed ID: 32929608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
    Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
    Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.
    Sonaglioni A; Baravelli M; Cassandro R; Torre O; Elia D; Anzà C; Harari S
    J Am Soc Echocardiogr; 2018 Aug; 31(8):888-901. PubMed ID: 29605474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
    Wu X; Xu W; Wang J; Tian X; Tian Z; Xu K
    Front Med; 2019 Apr; 13(2):259-266. PubMed ID: 29675687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sporadic lymphangioleiomyomatosis and pulmonary hypertension. Clinical and pathologic study in patients undergoing lung transplantation].
    Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
    Med Clin (Barc); 2012 May; 138(13):570-3. PubMed ID: 22440137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis.
    Song X; Cai H; Peng W; Chen K; Abuduxukuer Z; Zeng Y; Zhu G; Lu C; Chen Y; Wang J; Ye L; Jin M
    Respir Res; 2024 Jan; 25(1):57. PubMed ID: 38267973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis.
    Hu S; Wu X; Xu W; Tian X; Yang Y; Wang ST; Liu S; Xu X; Xu KF
    Orphanet J Rare Dis; 2019 Aug; 14(1):206. PubMed ID: 31429781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of lymphangioleiomyomatosis patients with discordance between spirometric and diffusion measurements of pulmonary function.
    Courtwright AM; Baldi BG; Kidambi P; Cui Y; Lamattina AM; Villalba JA; Bagwe S; Goldberg HJ; Rosas IO; Henske EP; Carvalho CRR; El-Chemaly S
    Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):206-212. PubMed ID: 32476904
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
    Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
    Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.